Abstract Details
|
Christen L. Shoesmith, MD, BSc, FÂé¶¹´«Ã½Ó³»
(University Hospital)
PRESENTER |
The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Agessandro Abrahao, Jr., MD (Sunnybrook Health Sciences Centre - University of Toronto) | Dr. Abrahao has nothing to disclose. |
| Timothy J. Benstead, MD | No disclosure on file |
| Marvin C. Chum, MD (St. Joseph's Healthcare Hamilton - Neuro-Diagnostics) | Dr. Chum has nothing to disclose. |
| No disclosure on file | |
| Aaron E. Izenberg, MD (Sunnybrook Health Sciences Centre) | Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. |
| Wendy Johnston, MD, FRCP(C), FÂé¶¹´«Ã½Ó³» (Universtiy of Alberta) | Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Sanjay Kalra, MD (University of Alberta) | The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen. |
| No disclosure on file | |
| Colleen M. O'Connell, CNP (Ohio State University Medical Center) | No disclosure on file |
| Kerri Schellenberg, MD | No disclosure on file |
| No disclosure on file | |
| Lorne H. Zinman, MD | Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. |